A Prospective, Randomized, Multicenter, Open-Label Study of High Dose Corticosteroids versus Conversion to Tacrolimus Therapy for Grade IIIa and Gradeb Rejection without Hemodynamic Compromis in Cardiac Transplant Recipients Receiving Primary